Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, et al. B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors. Transl Oncol. 2020;13(2):365-371.

Usui J, Yaguchi M, Yamazaki S, Takahashi-Kobayashi M, Kawamura T, Kaneko S, et al. Transcription factor 21 expression in injured podocytes of glomerular diseases. Sci Rep. 2020;10(1):11516.

Nicolau S, Tracy JA, Pisapia DJ, Tanji K, Milone M. : A distal myopathy with polyglucosan bodies. JIMD Rep. 2020;55(1):88-90.

Hellyer JA, Ouseph MM, Padda SK, Wakelee HA. Everolimus in the treatment of metastatic thymic epithelial tumors. Lung Cancer. 2020;149:97-102.

Magruder M, Edusei E, Zhang L, Albakry S, Satlin MJ, Westblade LF, et al. Gut commensal microbiota and decreased risk for bacteriuria and urinary tract infection. Gut Microbes. 2020;12(1):1805281.

Huang T-, Fowler F, Chen C-, Shen Z-, Sleckman B, Tyler JK. The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading onto ssDNA during Homologous Recombination in Human Cells. Mol Cell. 2020;77(5):1153.

Stopsack KH, Huang Y, Tyekucheva S, Gerke TA, Bango C, Elfandy H, et al. Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway Activation. Clin Cancer Res. 2020;26(22):5903-5913.

Dalton T, Doubrovina E, Pankov D, Reynolds R, Scholze H, Selvakumar A, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 2020;135(21):1870-1881.

Windon AL, Almazan E, Oliva-Hemker M, Hutchings D, Assarzadegan N, Salimian K, et al. Lymphocytic and collagenous colitis in children and adolescents: Comprehensive clinicopathologic analysis with long-term follow-up. Hum Pathol. 2020;106:13-22.

Gazivoda V, Kiss LP, Rhee R. A rare case of perianal apocrine adenocarcinoma. J Surg Case Rep. 2020;2020(11):rjaa463.